» Articles » PMID: 37758888

Molecular Pathology of Neurodegenerative Diseases by Cryo-EM of Amyloids

Overview
Journal Nature
Specialty Science
Date 2023 Sep 27
PMID 37758888
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal assembly of tau, α-synuclein, TDP-43 and amyloid-β proteins into amyloid filaments defines most human neurodegenerative diseases. Genetics provides a direct link between filament formation and the causes of disease. Developments in cryo-electron microscopy (cryo-EM) have made it possible to determine the atomic structures of amyloids from postmortem human brains. Here we review the structures of brain-derived amyloid filaments that have been determined so far and discuss their impact on research into neurodegeneration. Whereas a given protein can adopt many different filament structures, specific amyloid folds define distinct diseases. Amyloid structures thus provide a description of neuropathology at the atomic level and a basis for studying disease. Future research should focus on model systems that replicate the structures observed in disease to better understand the molecular mechanisms of disease and develop improved diagnostics and therapies.

Citing Articles

Mutant tau filaments from some inherited frontotemporal dementias show the Alzheimer fold.

Nat Struct Mol Biol. 2025; .

PMID: 40074886 DOI: 10.1038/s41594-025-01499-4.


Nanomedicine: a cost-effective and powerful platform for managing neurodegenerative diseases.

Hassanzadeh-Khanmiri M, Moshari A, Kheradmand R, Haghgouei T, Homaei M, Charsouei S Metab Brain Dis. 2025; 40(3):142.

PMID: 40067468 DOI: 10.1007/s11011-025-01564-3.


Tau filaments with the Alzheimer fold in human MAPT mutants V337M and R406W.

Qi C, Lovestam S, Murzin A, Peak-Chew S, Franco C, Bogdani M Nat Struct Mol Biol. 2025; .

PMID: 40044789 DOI: 10.1038/s41594-025-01498-5.


A novel alpha-synuclein K58N missense variant in a patient with Parkinson's disease.

Al-Azzani M, Weber S, Ramalingam N, Ramon M, Shvachiy L, Mestre G medRxiv. 2025; .

PMID: 39990587 PMC: 11844588. DOI: 10.1101/2025.02.07.25321793.


Guide to the structural characterization of protein aggregates and amyloid fibrils by CD spectroscopy.

Kardos J, Nyiri M, Moussong E, Wien F, Molnar T, Murvai N Protein Sci. 2025; 34(3):e70066.

PMID: 39968955 PMC: 11836901. DOI: 10.1002/pro.70066.


References
1.
Cohen A, CALKINS E . Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature. 1959; 183(4669):1202-3. DOI: 10.1038/1831202a0. View

2.
Glenner G, Wong C . Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984; 120(3):885-90. DOI: 10.1016/s0006-291x(84)80190-4. View

3.
Masters C, Simms G, Weinman N, Multhaup G, McDonald B, Beyreuther K . Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985; 82(12):4245-9. PMC: 397973. DOI: 10.1073/pnas.82.12.4245. View

4.
Goedert M, Wischik C, Crowther R, Walker J, Klug A . Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A. 1988; 85(11):4051-5. PMC: 280359. DOI: 10.1073/pnas.85.11.4051. View

5.
Spillantini M, Schmidt M, Lee V, Trojanowski J, Jakes R, Goedert M . Alpha-synuclein in Lewy bodies. Nature. 1997; 388(6645):839-40. DOI: 10.1038/42166. View